[Management View]
Exponent reported strong Q3 2025 results, with net revenues growing 10% YoY to $137.1 million, driven by demand for dispute-related and reactive engagements across energy, life sciences, transportation, and chemical regulatory projects. Management emphasized the company's diversified portfolio and ability to deliver value across industries. Strategic priorities include leveraging expertise in failure analysis, regulatory consulting, and human-machine interaction studies, while continuing to invest in talent development.

[Outlook]
For Q4 2025, Exponent expects net revenue growth in the low to mid-single digits, with EBITDA margins of 26%-27%. Full-year 2025 guidance includes low single-digit net revenue growth, EBITDA margins of 27.4%-27.65%, and utilization rates of approximately 72.5%. Hiring efforts will focus on growth areas such as digital health, automated vehicles, and energy sectors. Management remains optimistic about AI-related opportunities and anticipates balanced growth across proactive and reactive engagements.

[Financial Performance]
- Total revenues: $147.1 million (+8% YoY)
- Net revenues: $137.1 million (+10% YoY)
- Net income: $28 million ($0.55 per diluted share), up from $26 million ($0.50 per diluted share) in Q3 2024
- EBITDA: $38.8 million (+9% YoY), with a margin of 28.3% (down slightly from 28.6% in Q3 2024)
- Billable hours: 376,000 (+4% YoY)
- Utilization: 74.1% (up from 73.4% in Q3 2024)
- Realized rate increase: +6% YoY

[Q&A Highlights]
Question 1: Any early thoughts on 2026 hiring plans given strong demand and utilization trends?
Answer: Management confirmed strong recruiting momentum, targeting areas like digital health, automated vehicles, and energy. They anticipate headcount growth in the range of 4%-6% for 2026, returning to historical levels after trailing in recent years.

Question 2: Can AI-related projects be quantified, and are they more reactive or proactive?
Answer: AI is significantly integrated across industries, including electronics, medical devices, and energy. Projects span reactive (e.g., disputes and failures) and proactive (e.g., algorithm benchmarking and risk modeling) engagements. While difficult to quantify, AI is expected to grow as technology accelerates.

Question 3: How has proactive vs. reactive revenue growth trended year-to-date?
Answer: Reactive business grew 18% in Q3 2025, driven by disputes and failures, while proactive revenue was flat due to declines in consumer electronics hardware. Management expects improving trends in proactive engagements, particularly in human-machine interaction studies.

Question 4: What is the impact of regulatory dynamics under the current administration?
Answer: Regulatory work remains strong, particularly in chemicals and medical devices, with global frameworks driving growth. While some delays in feedback from agencies like the FDA and EPA were noted, enforcement actions have increased, supporting demand for Exponent's services.

Question 5: Has the government shutdown affected revenues or guidance?
Answer: Federal government contracts account for 2%-3% of revenues, with no significant short-term impact from the shutdown. Most ongoing projects are under contract and unaffected.

Question 6: How does hiring mix impact rate increases, and can the current 6% rate increase be sustained?
Answer: Rate increases benefited from strong demand for experienced personnel and modest hiring of junior staff. As hiring accelerates and more junior consultants join, rate increases are expected to normalize to historical levels of 3%-3.5%.

[Sentiment Analysis]
Analysts expressed optimism about Exponent's growth trajectory, particularly in reactive engagements and AI-related opportunities. Management maintained a confident tone, emphasizing strong demand, strategic hiring, and the company's ability to navigate regulatory and technological complexities.

[Quarterly Comparison]
| Metric | Q3 2025 | Q3 2024 | YoY Change |
|----------------------------|-----------------|-----------------|------------------|
| Total Revenues | $147.1 million | $136.2 million | +8% |
| Net Revenues | $137.1 million | $124.6 million | +10% |
| Net Income | $28 million | $26 million | +7.7% |
| EBITDA | $38.8 million | $35.8 million | +9% |
| EBITDA Margin | 28.3% | 28.6% | -0.3% |
| Billable Hours | 376,000 | 361,000 | +4% |
| Utilization | 74.1% | 73.4% | +0.7% |
| Realized Rate Increase | +6% | +4% | +2% |

[Risks and Concerns]
1. Rising G&A expenses (+44% YoY) due to talent development initiatives, including a $1.8 million managers meeting expense.
2. Potential normalization of realized rate increases as hiring shifts toward junior personnel.
3. Regulatory delays and uncertainties, though largely offset by global frameworks.
4. Limited exposure to federal government contracts (2%-3% of revenues), with potential risks from prolonged shutdowns.
5. Year-over-year revenue headwind in Q4 2025 due to fewer workdays compared to Q4 2024.

[Final Takeaway]
Exponent's Q3 2025 results highlight robust growth driven by reactive engagements and strategic rate increases. The company's diversified portfolio and expertise in failure analysis, regulatory consulting, and AI integration position it well for sustained growth. While proactive revenue remains flat, improving trends in human-machine interaction studies and regulatory consulting offer optimism for Q4 2025 and beyond. Management's focus on targeted hiring and talent development underscores confidence in long-term growth, despite rising costs and potential external risks. Investors should monitor utilization rates, hiring trends, and the balance between proactive and reactive engagements as key indicators of future performance.